Multiple market analysts recognise Euretos as leading AI company in drug development
At Euretos, we are driven by a deep desire to unravel the complexities of human disease biology. We are convinced that a better understanding of disease mechanisms on a molecular level reduces the risk and cost of therapy development. This leads to better and safer treatment options for more patients.
We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research.
We are very happy to share that our contribution to disease and drug research has been recognized by three prominent industry analyst reports recently:
We could not have achieved these recognitions without the combination of our client partnerships, our multi-disciplinary data & translational science teams and the Euretos AI platform. We arevery happy with our progress and excited about the future innovations we plan to deliver.
If you would like to know more about how we enable a data-driven approach to disease and drug research, don't hesitate to get in touch with us, and we will be happy to tell you more about it!
Subscribe to our mailing list and receive our quarterly updates!